HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tito Borner Selected Research

Appetite Depressants (Anorectics)

1/2022Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons.
1/2020GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss.
1/2020GDF15 Induces Anorexia through Nausea and Emesis.
1/2020GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats.
6/2017Anorexia-cachexia syndrome in hepatoma tumour-bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC-1/GDF15.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tito Borner Research Topics

Disease

14Anorexia
01/2022 - 08/2012
12Nausea
01/2022 - 01/2018
11Vomiting
01/2022 - 01/2020
8Obesity
01/2022 - 01/2018
7Body Weight (Weight, Body)
01/2022 - 01/2016
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2018
4Pica (Geophagia)
10/2021 - 01/2019
4Neoplasms (Cancer)
01/2020 - 01/2016
3Weight Loss (Weight Reduction)
01/2022 - 01/2021
3Cachexia
01/2018 - 01/2016
2Body Weight Changes
01/2019 - 01/2018
2Hepatocellular Carcinoma (Hepatoma)
01/2018 - 01/2016
2AIDS-Related Complex (ARC)
01/2016 - 08/2012
1Morning Sickness
01/2020

Drug/Important Bio-Agent (IBA)

7Glucagon-Like Peptide 1 (GLP 1)IBA
01/2022 - 01/2018
6Glucagon-Like Peptide-1 ReceptorIBA
11/2021 - 01/2018
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2018
5Appetite Depressants (Anorectics)IBA
01/2022 - 06/2017
3Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2022 - 01/2018
3Peptides (Polypeptides)IBA
01/2022 - 01/2021
3muskIBA
11/2021 - 01/2020
3EmeticsIBA
11/2021 - 01/2020
3GhrelinIBA
10/2021 - 08/2012
2gastric inhibitory polypeptide receptorIBA
01/2022 - 11/2021
2Growth Differentiation Factor 15IBA
01/2022 - 01/2020
2Pharmaceutical PreparationsIBA
11/2021 - 10/2021
2Serotonin (5 Hydroxytryptamine)IBA
10/2021 - 01/2019
2Exenatide (Byetta)FDA Link
01/2021 - 01/2018
1Peptide YYIBA
01/2022
1corrinIBA
01/2022
1Islet Amyloid PolypeptideIBA
01/2022
1pyrrolidonyl-beta-naphthylamideIBA
01/2022
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2022
1LigandsIBA
11/2021
1AntiemeticsIBA
10/2021
1Messenger RNA (mRNA)IBA
10/2021
1Cisplatin (Platino)FDA LinkGeneric
10/2021
1Olanzapine (Zyprexa)FDA Link
10/2021
1KaolinIBA
10/2021
1IncretinsIBA
01/2021
1LiraglutideFDA Link
01/2020
1CytokinesIBA
01/2020
1Ghrelin ReceptorsIBA
01/2016
1HM01IBA
01/2016
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2012
1N- ((3- (aminomethyl)phenyl)methyl)ethanimidamideIBA
08/2012
1LipopolysaccharidesIBA
08/2012
1Hormones (Hormone)IBA
08/2012

Therapy/Procedure

5Therapeutics
11/2021 - 06/2017
4Drug Therapy (Chemotherapy)
10/2021 - 01/2020
3Glycemic Control
11/2021 - 01/2020